Beyond prescription: Determinants of low-dose aspirin adoption and uptake across the pre-eclampsia prevention pathway in Nepal - a qualitative study guided by the COM-B model
In the authors' words
Despite strong evidence supporting low-dose aspirin (LDA) for preventing pre-eclampsia among women at risk, implementation remains suboptimal globally. The prevention pathway encompasses early antenatal care engagement, screening and risk identification, prescribing LDA, and medication uptake. This qualitative study explored barriers and facilitators to LDA adoption by providers (i.e., prescribing) and uptake among women in Nepal. A qualitative study was conducted with pregnant women, healthcare providers, and maternal and child health stakeholders in Nepal. Data collection and analysis were guided by the Capability, Opportunity, Motivation, and Behavior (COM-B) model. Participants were purposively recruited from three tertiary hospitals and maternal health organizations. Semi-structured interviews explored experiences and perspectives related to antenatal care, such as pre-eclampsia risk screening, LDA prescribing, and uptake. Data were analyzed using rapid qualitative analysis and organized according to the COM-B components. Seventy-three participants were interviewed, including 36 pregnant women, both at risk and not at risk for pre-eclampsia; 29 healthcare providers, including consultant/senior obstetricians, mid-level doctors, and nurses or midwives; and 8 maternal and child health stakeholders representing government, multi-lateral, non-governmental, professional, and academic institutions. LDA adoption and uptake were affected by interdependent gaps across the prevention pathway. Delayed antenatal care engagement and inconsistent screening limited timely identification of women at risk, while gaps in national guidance and standardized prescribing protocols contributed to variable provider prescribing practices. Among women prescribed LDA, clear counselling on its purpose and safety and trust in providers supported uptake. LDA adoption and uptake depend on a functioning prevention pathway in which women engage with antenatal care early enough for timely risk assessment, those at risk are identified through screening, providers prescribe appropriately, and women are supported to use the medication. Strengthening this pathway requires coordinated attention to health-system and provider capacity as well as communication with women, rather than strategies focused narrowly on prescribing or medication use. These findings will inform the development of implementation strategies for Nepal and other low-resource settings seeking to integrate evidence-based preventive interventions into maternal healthcare systems.
Appeared: Tuesday, November 17. medRxiv. Preprint, not yet peer-reviewed.